Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
5,020 people get CVS articles and Market Currents by email alert.
Get email alerts on CVS »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
Why We Like CVS CaremarkUlfberht Capital • Mon, Apr 8 -
-
-
-
-
-
-
-
-
-
Earnings Analysis: CVS CaremarkCapitalCube • Wed, Nov 7, 2012 -
Watch For Walgreen-Express Scripts Impact In CVS Caremark EarningsTrefis • Mon, Nov 5, 2012
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
CVS Caremark's CEO Hosts 2012 Analyst Day (Transcript)Thu, Dec 13, 2012
-
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012 • 1 Comment
-
CVS Caremark Corporation - Analyst/Investor DayTue, Dec 20, 2011
-
CVS Caremark's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Nov 3, 2011 • 1 Comment
-
CVS Caremark Corporation Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
CVS Caremark Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
CVS Caremark Corporation Q4 2009 Earnings Call TranscriptMon, Feb 8, 2010
-
CVS Caremark Q3 2009 Earnings Call TranscriptThu, Nov 5, 2009
-
CVS Caremark Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
at CNBC.com (Wed, 2:43PM)
-
at CNBC.com (Thu, 6:17PM)
-
PR Newswire (Jun 11, 2013)
-
at Fox Business (Jun 7, 2013)
-
PR Newswire (Jun 3, 2013)
-
at CNBC.com (May 30, 2013)
-
PR Newswire (May 23, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
at Fox Business (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at Fox Business (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
PR Newswire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
CVS vs. ETF Alternatives
Company Description
CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”) is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, August 23, 2011, 9:48 AM Drugstore companies are in the spotlight today of analysts. Barclays lowers its rating on shares of Walgreen's (WAG -3.1%) to Underweight from Equalweight, while Citi slashes price targets on CVS Caremark (CVS +0.2%) to $41 from $46 and on WAG to $42 from $48. 1 Comment [Consumer]
- Thursday, August 4, 2011, 8:41 AM More on CVS Caremark (CVS -2.8%) Q2s. Net profit of $816M was $4M below last year; retail pharmacy revs +3.6% to $14.8B; pharmacy services revs +23.2% to $14.6B. Modifies EPS guidance to $2.75-$2.81 vs. prior forecast of $2.72-$2.82 and analyst expectations of $2.78. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 4, 2011, 7:36 AM More on CVS' (CVS) Q2 report: Pharmacy services revenue $14.6B (+23.2% Y/Y) on strength of long-term contract with Aetna and acquisition. Increases free cash flow $800M, up to $2.4B YTD. Narrows FY11 EPS guidance to $2.75-$2.81, from earlier $2.72-$2.82. (PR) Comment! [Earnings, On the Move]
- Thursday, August 4, 2011, 7:12 AM CVS Caremark (CVS): Q2 EPS of $0.65 in-line. Revenue of $26.6B (+10.9% Y/Y) misses by $100M. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 4, 2011, 12:05 AM Notable earnings before Thursday's open: AEE, ANR, APA, ARCC, CAH, CCJ, CI, CNP, CNQ, CVS, DISCA, DF, DNR, DTV, EIX, EP, FIG, GM, GPOR, HCN, HUN, IVR, LEA, LUV, NRG, PCG, PGN, PXP, SBH, SINA, SUG, TBL, TDC, TE, TS, VRX, VTR, WNR Comment! [Earnings]
- Friday, July 22, 2011, 8:49 AM Analysts see strong opposition to the $29B merger of Express Scripts (ESRX) and Medco (MHS), which would leave the industry with just one other independent company, CVS. “It’s going to be a very tough fight through the Federal Trade Commission,” industry consultant Adam Fein says, expecting pharmacists and drug makers to try to block the deal. Comment! [Healthcare, M&A]
- Thursday, July 21, 2011, 1:08 PM Shares of retail pharmacies Walgreen (WAG -3.7%) and CVS (CVS +2.9%) move in opposite directions as a result of the merger of Express Scripts (ESRX +5.7%) and Medco (MHS +15.1%). With Medco and ESRX focused on integrating, CVS may be able to swipe some customers. But with WAG losing its contract with ESRX, it may have few alternatives for pharmacy benefit services. 1 Comment [Healthcare, Consumer, M&A]
- Tuesday, June 21, 2011, 9:38 AM CVS Caremark (CVS +1.2%) shares open higher after Walgreen (WAG -6.5%) says it will end its contract with CVS rival Express Scripts (ESRX -0.6%). Also helping is yesterday's announcement from Calpers, the largest U.S. public pension, that it picked CVS to administer prescription drug benefits to its members in a contract worth ~$565M annually. Comment! [Healthcare, On the Move]
-
Friday, May 27, 2011, 9:00 AM
Premarket gainers: AATI +55%. RUE +15%. MRVL +9%. VHC +6%. LDK +4%. CVS +4%. STO +3%. IBN +3%. HMY +3%.
Losers: MHS -11%. BCSI -7%. OVTI -4%. GLUU -4%. BWP -3%. CTICD -3%. WTW -3%. MMYT -3%. Comment! [On the Move] - Friday, May 27, 2011, 8:36 AM CVS Caremark (CVS) confirms it will receive the $3B/year Blue Cross FEP contract snatched out of Medco Health Solutions' (MHS) hands (PR). Shares of CVS now +6.7% while ESRX, a hopeful, is back to par. MHS still -13%. Comment! [Healthcare, Breaking News, On the Move, Top Stories]
- Friday, May 27, 2011, 8:25 AM Medco Health Solutions (MHS -13%) says the Blue Cross is shifting its mail order and specialty pharmacy benefit coverage for the Federal Employee Program to an alternate provider at year-end. The contract generates nearly $3B in annual revenue - almost 10% of current earnings (8-K). Rivals CVS and ESRX are up 4.6% and 2.5%. Comment! [Healthcare, On the Move, Breaking News]
- Thursday, May 12, 2011, 5:35 PM Worry over U.S. budget deficits was pervasive at the Skybridge conference, but equally consistent was the notion that "right now, we're OK." Add Leon Cooperman to those able to compartmentalize: "We're heading for a crisis. I just don't know when. [But until then] equities are the best value in a bad neighborhood" - specifically, GM, ETFC, RIG, TEVA, CVS. 4 Comments [Quick Ideas]
- Friday, May 6, 2011, 7:44 AM CVS Caremark (CVS) said yesterday that it received a subpoena from the SEC in February requesting information about public disclosures it made in 2009 on its struggling Caremark pharmacy-benefits management division and its Medicare Part D business. Comment! [Healthcare]
- Thursday, May 5, 2011, 7:09 AM CVS Caremark (CVS): Q1 EPS of $0.57 beats by $0.02. Revenue of $25.88B (+9% Y/Y) beats by $0.01B. (PR) Comment! [Earnings]
- Thursday, May 5, 2011, 12:05 AM Notable earnings before Thursday's open: AEE, BPO, CI, CNP, CTL, CVC, CVS, DNR, DTV, DPZ, EL, EP, FIG, FO, FTO, FTR, GM, GPOR, HK, HOC, HUN, ING, LYG, NOG, NRG, ONNN, PDE, PEG, PGN, PMI, PNCL, PPL, PXP, RVSN, SLE, SNI, SPR, TDC, VTR, WNR, WWE Comment! [Earnings]
- Monday, May 2, 2011, 2:46 PM Mario Gabelli replaces all of his Focus Five stock picks. In: Ascent Media (ASCMA), Coca-Cola Enterprises (CCE), CVS Caremark (CVS), Navistar (NAV), Yahoo (YHOO). Out: BlackRock (BLK), ITT (ITT), Madison Square Garden (MSG), National Fuel Gas (NFG), NII Holdings (NIHD). 3 Comments [Quick Ideas]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
Christopher Davis, Kenneth Feinberg - Clipper Q2-2011 Fund Portfolio http://bit.ly/oppRNt + $AXP $COST $OAKT-I $CNQ $BRK.A $L $IRM $CVS $HOG - View all 0 replies
-
- View all 0 replies
-
techguru99
I think Walgreen's and CVS should be very worried about what COST is doing in prescription drugs. http://bit.ly/roXCRD - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES